Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alivus Life Sciences Ltd.	Income Statement

NSE: ALIVUSEQ BSE: 543322ISIN: INE03Q201024INDUSTRY: Pharmaceuticals

BSE

Rs 1001.25

Open: 1022.25

Today's Range 994.10

1026.35

NSE
Rs 1000.60
-30.50 ( -3.05 %)

-29.05 ( -2.90 %)

Prev Close: 1030.30

52 Week Range 827.10

1335.00

You can view the Income Statement for the last 5 years.

Market Cap. (Rs.)	12270.27 Cr.	P/BV	4.83	Book Value (Rs.)	207.01
52 Week High/Low (Rs.)	1335/850	FV/ML	2/1	P/E(X)	25.27
Bookclosure	17/10/2023	EPS (Rs.)	39.60	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	2386.88	2184.77	2047.84	2087.45	1861.40
Other Operating Revenues	0.00	98.44	113.38	35.77	23.77
Total Operating Revenues	2386.88	2283.21	2161.22	2123.21	1885.17

Other Income	34.57	12.04	28.96	14.70	0.81
Total Revenue	2421.45	2295.26	2190.18	2137.92	1885.98

EXPENSES
Cost Of Materials Consumed	1053.50	1058.58	1098.53	1001.56	976.20
Operating And Direct Expenses	0.00	3.17	2.48	2.66	1.82
Changes In Inventories Of FG,WIP And Stock-In Trade	27.35	-56.57	-84.44	41.32	-70.70
Employee Benefit Expenses	251.70	258.16	180.18	168.72	149.13
Finance Costs	2.41	1.55	0.55	27.96	87.55
Depreciation And Amortisation Expenses	60.61	53.45	42.09	37.88	33.39
Other Expenses	371.75	345.63	322.18	292.89	237.65
Total Expenses	1767.32	1663.97	1561.57	1572.99	1415.03

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	654.13	631.29	628.61	564.93	470.94

Profit/Loss Before Tax	654.13	631.29	628.61	564.93	470.94

Tax Expenses-Continued Operations
Current Tax	168.50	152.21	150.61	137.63	112.75
Deferred Tax	0.00	8.19	11.04	8.57	6.62
Total Tax Expenses	168.50	160.40	161.65	146.20	119.36
Profit/Loss After Tax And Before ExtraOrdinary Items	485.63	470.89	466.96	418.72	351.58

Profit/Loss From Continuing Operations	485.63	470.89	466.96	418.72	351.58

Profit/Loss For The Period	485.63	470.89	466.96	418.72	351.58

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	39.63	38.43	38.11	35.63	32.61
Diluted EPS (Rs.)	39.52	38.38	38.11	35.63	32.61

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	275.69	385.96	128.65	0.00
Equity Dividend Rate (%)	250.00	1125.00	1050.00	1050.00	0.00

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alivus Life Sciences Ltd.

Income Statement